From Eternal and IndusInd Bank to Adani Power and BPCL, this week's Q1 FY27 results have delivered a genuinely dispersed set of outcomes — reminding investors that India's earnings season is rarely a single, uniform story
CLSA, Nomura, Goldman Sachs, Citi, and Elara Securities have all revised their targets on Dr Reddy's Laboratories downward this week — a rare moment of near-unanimous caution from a normally more divided analyst community
Shares of SBI Mutual Fund's parent company debuted at a 6.8% premium to their issue price, capping a strongly subscribed IPO that offers a window into how investors are pricing India's rapidly growing asset management industry
A toxic combination of surging crude prices, sustained foreign investor selling, and a resilient dollar has pushed the Indian rupee to within striking distance of its all-time low, forcing the RBI into another round of active market intervention
With crude prices spiking on West Asia tensions, the rupee sliding toward record lows, and equity markets extending a four-day losing streak, precious metals are once again drawing investor attention as India's classic hedge against uncertainty
The funding round, aimed at expanding Veriqus's integrated wealth and asset management offerings, arrives at a moment when India's rapidly growing base of affluent and mass-affluent investors is reshaping demand for sophisticated, technology-driven financial advisory platforms
The Nifty slipped below the psychologically important 24,000 mark and the Sensex shed nearly 400 points on July 23, as elevated crude oil prices, a weakening rupee, and sustained foreign institutional selling combined to sour investor sentiment ahead of Friday's open
India's largest private lender posted healthy double-digit growth in advances and a resilient deposit franchise in Q1 FY27, yet the stock's post-results reaction shows just how high the bar has been set for a bank this size
A one-time provision tied to disrupted semaglutide supplies, combined with weaker North America generics sales, triggered a brutal sell-off in Dr Reddy's shares — and a wave of brokerage downgrades questioning how quickly the pharma major can recover
The beverage giant's reported move to appoint global investment banks signals serious intent to unlock value in its local bottling operations and deepen retail distribution across the country